Stay updated on GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Sign up to get notified when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.

Latest updates to the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality.SummaryDifference0.1%
- Check21 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding RVT-1401 for Graves' Ophthalmopathy, while a new version number has been added.SummaryDifference15%
- Check28 days agoNo Change Detected
- Check36 days agoNo Change Detected
- Check79 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check86 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check108 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
Stay in the know with updates to GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.